ProPhase Labs Inc (PRPH)

0.6105 -0.04 (-6.52%) USD  |  NASDAQ  |  Dec 20, 16:00
0.6105 0.00 (0.00%) After-Hours: 20:00
More

ProPhase Labs Debt to Equity Ratio: 0.4506 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for PRPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Fonar Corp 0.0005
XWELL Inc 0.00
Applied DNA Sciences Inc 0.00
Veracyte Inc 0.00
OncoCyte Corp 0.00

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 91.81M
Total Liabilities (Quarterly) 53.68M
Shareholders Equity (Quarterly) 38.13M
Current Ratio 1.472
Net Debt Paydown Yield -3.26%